In contrast to the promotive effects of PCDH7 in breast and lung cancer, downregulated PCDH7 correlates with advanced grade, larger tumor size, and poorer overall survival in bladder cancer and gastric cancer patients (Lin et al., 2016; Chen et al., 2017). Here, PCDH7 is linked to gastric cancer.